Marketing-authorisation holder · Serbia
Medis Pharma D.o.o. Beograd
67 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Serbia
67 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 67
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Albiomin 20%200g/L · rastvor za infuziju | Albumin, Humani | Serbia | Authorised | 2024 |
| Alvesco®160mcg/doza · rastvor za inhalaciju pod pritiskom | Ciclesonide | Serbia | Authorised | 2021 |
| Alvesco®80mcg/doza · rastvor za inhalaciju pod pritiskom | Ciclesonide | Serbia | Authorised | 2021 |
| Avonex®30mcg/0.5mL · rastvor za injekciju u napunjenom injekcionom špricu | Interferon beta-1a | Serbia | Authorised | 2025 |
| Avonex®30mcg/0.5mL · rastvor za injekciju u napunjenom injekcionom špricu | Interferon beta-1a | Serbia | Authorised | 2025 |
| Cosopt®20mg/mL+5mg/mL · kapi za oči, rastvor | Dorzolamide, Timolol | Serbia | Authorised | 2024 |
| Ducressa®1mg/mL+5mg/mL · kapi za oči, rastvor | Dexamethasone, Levofloxacin | Serbia | Authorised | 2023 |
| Haemoctin SDH500i.j./5mL · prašak i rastvarač za rastvor za injekciju | Antihemophilic factor | Serbia | Authorised | 2024 |
| Haemoctin SDH1000i.j./5mL · prašak i rastvarač za rastvor za injekciju | Antihemophilic factor | Serbia | Authorised | 2024 |
| Haemonine 1000100i.j./mL · prašak i rastvarač za rastvor za injekciju | Coagulation factor ix | Serbia | Authorised | 2021 |
| Haemonine 500100i.j./mL · prašak i rastvarač za rastvor za injekciju | Coagulation factor ix | Serbia | Authorised | 2021 |
| Hepatect CP50i.j./mL · rastvor za infuziju | Hepatitis b immunoglobulin | Serbia | Authorised | 2021 |
| Hepatect CP50i.j./mL · rastvor za infuziju | Hepatitis b immunoglobulin | Serbia | Authorised | 2021 |
| Hepatect CP50i.j./mL · rastvor za infuziju | Hepatitis b immunoglobulin | Serbia | Authorised | 2021 |
| Ikervis®1mg/mL · kapi za oči, emulzija | Ciclosporin | Serbia | Authorised | 2025 |
| Intratect100mg/mL · rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2023 |
| Intratect100mg/mL · rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2023 |
| Intratect50mg/mL · rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2025 |
| Intratect50mg/mL · rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2025 |
| Intratect100mg/mL · rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2023 |
| Intratect50mg/mL · rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2025 |
| Intratect50mg/mL · rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2025 |
| Keppra®100mg/mL · oralni rastvor | Levetiracetam | Serbia | Authorised | 2025 |
| Keppra®500mg · film tableta | Levetiracetam | Serbia | Authorised | 2025 |
| Keppra®100mg/mL · oralni rastvor | Levetiracetam | Serbia | Authorised | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Serbia | 67 | 65 | 2 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.